机制(生物学)
小桶
安普克
药理学
2型糖尿病
对接(动物)
信号转导
胰岛素抵抗
医学
胰岛素受体
计算生物学
生物信息学
胰岛素
生物
糖尿病
磷酸化
内科学
细胞生物学
内分泌学
生物化学
蛋白激酶A
基因本体论
基因
护理部
基因表达
哲学
认识论
作者
Piaopiao Zhao,Xiaoxiao Zhang,Yuning Gong,Weihua Li,Zengrui Wu,Yun Tang,Guixia Liu
标识
DOI:10.1007/s40203-022-00124-2
摘要
Shen Qi Wan (SQW) prescription has been used to treat type 2 diabetes mellitus (T2DM) for thousands of years, but its pharmacological mechanism is still unclear. The network pharmacology method was used to reveal the potential pharmacological mechanism of SQW in the treatment of T2DM in this study. Nine core targets were identified through protein-protein interaction (PPI) network analysis and KEGG pathway enrichment analysis, which were AKT1, INSR, SLC2A1, EGFR, PPARG, PPARA, GCK, NOS3, and PTPN1. Besides, this study found that SQW treated the T2DM through insulin resistance (has04931), insulin signaling pathway (has04910), adipocytokine signaling pathway (has04920), AMPK signaling pathway (has04152) and FoxO signaling pathway (has04068) via ingredient-hub target-pathway network analysis. Finally, molecular docking was used to verify the drug-target interaction network in this research. This study provides a certain explanation for treating T2DM by SQW prescription, and provides a certain angle and method for researchers to study the mechanism of TCM in the treatment of complex diseases.The online version contains supplementary material available at 10.1007/s40203-022-00124-2.
科研通智能强力驱动
Strongly Powered by AbleSci AI